These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8584749)

  • 1. Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain.
    Ogawa S; Brown HE; Okano HJ; Pfaff DW
    Regul Pept; 1995 Oct; 59(2):143-9. PubMed ID: 8584749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat.
    Yee F; Ericson H; Reis DJ; Wahlestedt C
    Cell Mol Neurobiol; 1994 Oct; 14(5):475-86. PubMed ID: 7621508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of intracerebroventricularly injected antisense oligonucleotides in the mouse brain.
    Chauhan NB
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):353-7. PubMed ID: 12477284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors.
    Biessen EA; Vietsch H; Kuiper J; Bijsterbosch MK; Berkel TJ
    Mol Pharmacol; 1998 Feb; 53(2):262-9. PubMed ID: 9463484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.
    Hélin V; Gottikh M; Mishal Z; Subra F; Malvy C; Lavignon M
    Biochem Pharmacol; 1999 Jul; 58(1):95-107. PubMed ID: 10403523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential distribution of oligodeoxynucleotides in developing organs with epithelial-mesenchymal interactions.
    Rothenpieler UW; Dressler GR
    Nucleic Acids Res; 1993 Oct; 21(21):4961-6. PubMed ID: 8177746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.
    Islam A; Handley SL; Thompson KS; Akhtar S
    J Drug Target; 2000; 7(5):373-82. PubMed ID: 10721799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.
    Lorenz P; Misteli T; Baker BF; Bennett CF; Spector DL
    Nucleic Acids Res; 2000 Jan; 28(2):582-92. PubMed ID: 10606658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression.
    Standifer KM; Jenab S; Su W; Chien CC; Pan YX; Inturrisi CE; Pasternak GW
    J Neurochem; 1995 Nov; 65(5):1981-7. PubMed ID: 7595481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells.
    Li B; Hughes JA; Phillips MI
    Neurochem Int; 1997 Sep; 31(3):393-403. PubMed ID: 9246681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense inhibition of the brain kallikrein-kinin system.
    Madeddu P; Parpaglia PP; Glorioso N; Chao L; Chao J
    Hypertension; 1996 Dec; 28(6):980-7. PubMed ID: 8952586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
    Sánchez-Blázquez P; García-España A; Garzón J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system.
    Whitesell L; Geselowitz D; Chavany C; Fahmy B; Walbridge S; Alger JR; Neckers LM
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4665-9. PubMed ID: 8506315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo delivery of phosphorothioate oligonucleotides into murine retina.
    Hangai M; Tanihara H; Honda Y; Kaneda Y
    Arch Ophthalmol; 1998 Mar; 116(3):342-8. PubMed ID: 9514488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides.
    Jachimczak P; Fabel-Schulte K; Hessdörfer B; Brysch W; Schlingensiepen KH; Blesch A; Bogdahn U
    Cell Immunol; 1995 Oct; 165(1):125-33. PubMed ID: 7671316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo.
    Carome MA; Kang YH; Bohen EM; Nicholson DE; Carr FE; Kiandoli LC; Brummel SE; Yuan CM
    Nephron; 1997; 75(1):82-7. PubMed ID: 9031275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization.
    Yaida Y; Nowak TS
    Regul Pept; 1995 Oct; 59(2):193-9. PubMed ID: 8584754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.